ZA886757B - Preservative system for ophthalmics formulations - Google Patents

Preservative system for ophthalmics formulations

Info

Publication number
ZA886757B
ZA886757B ZA886757A ZA886757A ZA886757B ZA 886757 B ZA886757 B ZA 886757B ZA 886757 A ZA886757 A ZA 886757A ZA 886757 A ZA886757 A ZA 886757A ZA 886757 B ZA886757 B ZA 886757B
Authority
ZA
South Africa
Prior art keywords
formulations
preservative system
ophthalmics
preservative
caused
Prior art date
Application number
ZA886757A
Other languages
English (en)
Inventor
Cherng-Chyi Roger Fu
Roger Fu Cherng-Chyi
Deborah Marilyn Lidgate
Marilyn Lidgate Deborah
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22256043&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA886757(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of ZA886757B publication Critical patent/ZA886757B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA886757A 1987-09-11 1988-09-09 Preservative system for ophthalmics formulations ZA886757B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9617387A 1987-09-11 1987-09-11

Publications (1)

Publication Number Publication Date
ZA886757B true ZA886757B (en) 1990-05-30

Family

ID=22256043

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA886757A ZA886757B (en) 1987-09-11 1988-09-09 Preservative system for ophthalmics formulations

Country Status (17)

Country Link
EP (1) EP0306984B1 (de)
JP (1) JPH0696542B2 (de)
KR (1) KR950013754B1 (de)
AT (1) ATE74750T1 (de)
AU (1) AU626798B2 (de)
CA (1) CA1328614C (de)
DE (1) DE3870111D1 (de)
DK (1) DK174702B1 (de)
FI (1) FI94924C (de)
HK (1) HK27894A (de)
HU (2) HU199072B (de)
IE (1) IE60717B1 (de)
IL (1) IL87724A (de)
NO (1) NO175404C (de)
NZ (1) NZ226100A (de)
PH (1) PH25422A (de)
ZA (1) ZA886757B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5414011A (en) * 1987-09-11 1995-05-09 Syntex (U.S.A.) Inc. Preservative system for ophthalmic formulations
ATE103182T1 (de) * 1989-09-21 1994-04-15 Ciba Vision Ag Antimikrobielle zusammensetzungen.
IL95942A0 (en) * 1989-10-13 1991-07-18 Syntex Inc Collagen-containing ophthalmic formulation
US5464609A (en) * 1990-03-16 1995-11-07 The Procter & Gamble Company Use of ketorolac for treatment of oral diseases and conditions
JP3140050B2 (ja) * 1990-03-16 2001-03-05 ザ、プロクター、エンド、ギャンブル、カンパニー 歯周病の治療に関するケトロラックの用法
EP0766970A3 (de) * 1990-12-27 2000-02-23 Allergan, Inc Verfahren und Zusammensetzung zum Desinfizieren von Kontaktlinsen
US5227152A (en) * 1991-04-09 1993-07-13 Merck Frosst Canada, Inc. Radiopharmaceutical bacteriostats
US5306482A (en) * 1991-04-09 1994-04-26 Merck Frosst Canada, Inc. Radiopharmaceutical bacteriostats
US5093105A (en) * 1991-04-09 1992-03-03 Merck Frosst Canada, Inc. Radiopharmaceutical bacteriostats
JPH09506620A (ja) * 1993-12-17 1997-06-30 アルコン・ラボラトリーズ，インコーポレイテッド 非ステロイド抗炎症剤を含有する改良された眼内洗浄溶液
US5474985A (en) * 1993-12-22 1995-12-12 The Regents Of The University Of California Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
ES2079320B1 (es) * 1994-05-17 1996-10-16 Cusi Lab Disolucion oftalmica a base de un diclofenaco y tobramicina y sus aplicaciones.
WO1995033456A2 (en) * 1994-06-07 1995-12-14 Telor Ophthalmic Pharmaceuticals, Inc. Reducing intraocular pressure using aryloxy- and aryl-acetic acids
WO1996011003A1 (en) * 1994-10-10 1996-04-18 Novartis Ag Ophthalmic and aural compositions containing diclofenac potassium
US5603929A (en) * 1994-11-16 1997-02-18 Alcon Laboratories, Inc. Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
ATE215821T1 (de) * 1995-01-20 2002-04-15 Wakamoto Pharma Co Ltd Entzündungshemmende augentropfen
US5599535A (en) * 1995-06-07 1997-02-04 Regents Of The University Of California Methods for the cyto-protection of the trabecular meshwork
US5674888A (en) * 1995-06-07 1997-10-07 University Of California Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
TW434023B (en) * 1995-09-18 2001-05-16 Novartis Ag Preserved ophthalmic composition
JPH09278653A (ja) * 1996-04-05 1997-10-28 Santen Pharmaceut Co Ltd 網膜疾患治療剤
MX9701946A (es) * 1997-03-14 1998-04-30 Arturo Jimenez Bayardo Solucion oftalmica transportadora.
DE19729879C2 (de) 1997-07-11 1999-07-08 Mann Gerhard Chem Pharm Fab Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin
JP2006111636A (ja) * 1997-12-26 2006-04-27 Astellas Pharma Inc 徐放性医薬組成物
CN101711737A (zh) * 1999-03-02 2010-05-26 透明视网膜技术公司 玻璃体内给药的用于治疗或预防眼科疾病的药剂
DE19918324A1 (de) * 1999-04-22 2000-10-26 Mann Gerhard Chem Pharm Fab Pharmazeutische Zusammensetzung wirksam gegen durch Bakterien, Viren, Pilze, Hefen und Protozoen verursachte Krankheitszustände
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
PT1586316E (pt) 2003-01-21 2008-05-28 Senju Pharma Co Preparação líquida aquosa contendo ácido 2-amino-3-(4- bromobenzoil)fenilacético
US8008338B2 (en) 2003-06-03 2011-08-30 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
CA2534484A1 (en) 2003-08-07 2005-02-17 Allergan, Inc. Compositions for delivery of therapeutics into the eyes and methods for making and using same
EP1568369A1 (de) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam zur Behandlung von Atemwegserkrankungen bei Schweinen
WO2005102303A2 (en) * 2004-04-21 2005-11-03 Advanced Ocular Systems Limited Antiprostaglandins for the treatment of ocular pathologies
US9161905B2 (en) * 2005-01-12 2015-10-20 Ocular Research Of Boston, Inc. Dry eye treatment
US9192571B2 (en) 2008-03-03 2015-11-24 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
MX389960B (es) 2009-10-12 2025-03-20 Boehringer Ingelheim Vetmedica Gmbh Recipientes para composiciones que comprenden meloxicam.
CA2791805A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
JP2013082682A (ja) * 2011-09-29 2013-05-09 Senju Pharmaceut Co Ltd 亜塩素酸塩を含有する水性製剤
CN110448530A (zh) * 2018-05-07 2019-11-15 北京蓝丹医药科技有限公司 一种氟比洛芬酯注射液

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087538A (en) * 1976-09-09 1978-05-02 Merck & Co., Inc. Ophthalmic suspensions
DE3026402A1 (de) * 1980-07-11 1982-02-04 Syntex Corp., Palo Alto, Calif. Die verwendung analgetischer und nicht-hormonaler, entzuendungshemmender mittel bei der behandlung von mikrovaskulaeren erkrankungen
KR930000029B1 (ko) * 1984-03-14 1993-01-06 제롬 꼬르비에르 N-아실 인돌류 활성성분의 용해방법

Also Published As

Publication number Publication date
HK27894A (en) 1994-03-31
DK505688D0 (da) 1988-09-09
DK505688A (da) 1989-03-12
DE3870111D1 (de) 1992-05-21
FI884160A0 (fi) 1988-09-09
HUT47839A (en) 1989-04-28
IE882740L (en) 1989-03-11
FI884160L (fi) 1989-03-12
KR950013754B1 (ko) 1995-11-15
JPH01104023A (ja) 1989-04-21
NO884020L (no) 1989-03-13
DK174702B1 (da) 2003-09-29
AU626798B2 (en) 1992-08-13
CA1328614C (en) 1994-04-19
IE60717B1 (en) 1994-08-10
FI94924B (fi) 1995-08-15
KR890004691A (ko) 1989-05-09
PH25422A (en) 1991-07-01
NO884020D0 (no) 1988-09-09
NZ226100A (en) 1990-12-21
FI94924C (fi) 1995-11-27
HU199072B (en) 1990-01-29
AU2204288A (en) 1989-03-16
IL87724A0 (en) 1989-02-28
HU210610A9 (en) 1995-05-29
IL87724A (en) 1992-01-15
ATE74750T1 (de) 1992-05-15
EP0306984B1 (de) 1992-04-15
NO175404C (no) 1994-10-12
EP0306984A1 (de) 1989-03-15
JPH0696542B2 (ja) 1994-11-30
NO175404B (no) 1994-07-04

Similar Documents

Publication Publication Date Title
ZA886757B (en) Preservative system for ophthalmics formulations
CA2013188A1 (en) Preservative system for ophthalmic formulations
KR100260061B1 (en) Vitamin e drop
PT781547E (pt) Formulacao oftalmica a base de hialuronato de sodio para utilizacao em cirurgia ocular
DE69426529D1 (de) Ophthalmische lösung, die diclofenac und tobramycin enthält, und ihre verwendung
LV10688A (lv) Pretalergisks sastavs oftalmologijai vai deguna slimibam
DE69333927D1 (de) Agglomerierte hydrophile Komplexe mit mehrphasigen Abgabeeigenschaften
EP1378247A4 (de) Wirkstoffe zur behandlung von sehfunktionsstörungen
Edelhauser et al. Corneal edema and the intraocular use of epinephrine
ATE251458T1 (de) Nervenschutzende für auge von säugern unter anwendung von kaliumkanalblockern
CA2129635A1 (en) Method of Ophthalmic Drug Delivery
IE811654L (en) Ophthalmic composition
Chen et al. Bee sting-induced ocular changes
ES2131373T3 (es) Composicion oftalmica para prevenir o tratar el ojo seco o una enfermedad causada por el mismo, que comprende acido 12-sulfodeshidroabietico.
EP1110554A4 (de) Medizinische zusammensetzungen zur behandlung von augenerkrankungen
EP1410808A4 (de) Mittel zum schutz des sehnervs mit alpha-1-rezeptor-blocker als wirkstoff
EP0451869A3 (en) Use of steroid derivatives in the treatment of endometriosis
Joo et al. Outflow of aqueous humor following cyclodialysis or ciliochoroidal detachment in rabbit
RU99103106A (ru) Способ лечения отслойки цилиарного тела
SU1357021A1 (ru) Средство, уменьшающее проницаемость капилл ров, снижающее агрегацию тромбоцитов, дл лечени внутриглазных кровоизли ний
EIM et al. EVALUATION OF GENTA MICIN SULFATE IN AQUEOUS HUMOR OF DONKEYS FOLLOWING ITS ADMINISTRATION
Wegener et al. Benefit/risk assessment of ophthalmic anti-infectives
Gelatt Multifocal ocular histoplasmosis in a dog and cat: by RM Gwin, Torrence A. Makley, Jr., Milton Wyman, and Kathryn Werling. J Am Vet Med Assoc 176: 638–642, 1980
Kronfeld et al. Bangerter, A. Some plastic surgical procedures. Ophthalmologica 120: 83-92, July-Aug., 1950.
JPS574920A (en) Prescription of 5-fluoro-2-methyl-1- (p-methylthiobenzylidene)-3-indenylacetic acid